Ft. Caldwell et al., Chronic indomethacin administration blocks increased body temperature after burn injury in rats, J BURN CARE, 19(6), 1998, pp. 501-511
This study investigates the hypothesis that continuous administration of in
domethacin (a cyclo-oxygenase inhibitor) will chronically reduce body tempe
rature (T-B) in burned rats (ie, modulate "true" fever). Male Sprague-Dawle
y rats had radio transmitters and osmotic pumps (containing indomethacin) p
laced in the peritoneal cavity, and 7 days later large full-thickness scald
burns were produced. Activity and T-B were continually recorded through th
e 14th postburn day (PBD). There were 4 experimental groups: burn + indomet
hacin (B-In), n = 9; burn + polyethylene glycol (B-Peg), it = 6; control indomethacin (C-In), n = 9; and control + polyethylene glycol (C-Peg), rt =
6. From PBD 5 through PBD 10, the B-Peg group had consistently and signifi
cantly higher T-B during light hours than the B-In, C-In, and C-reg groups.
From PBD 7 through PBD 12, the B-In group had an average T-B during light
hours significantly lower or not different than the C-In and C-Peg groups.
These results support the hypothesis that in this burned-rat model chronica
lly increased T-B during the light hours may be "fever" (rather than hypert
hermia) and that the final effector Link could be a prostanoid because chan
ges in activity do not explain the changes in body temperature.